Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Transactions / D••••••• H••••• I• I•••

D• H••••••••• P••••••• Announces Sale of D••••••• to F•••••••••

Add-on acquisitionannouncedadd-onannounced Mar 15, 2024Fact
What happened
Platform
F••••••••• S•••••• G•••add-on basis: Toronto, ON (March 15, 2024) – D• H••••••••• P••••••• (“DWHP”) a healthcare-focused private equity firm, announced today the sale of D••••••• H••••• I• I••• (“D•••••••”) to F••••••••• S•••••• G••• (“F•••••••••”), a portfolio company of E•• P•••••••.
Control
Control
Share acquired
unknown
Industry
healthcare / dermatolog, healthcare
Target location
unknown
Seller kind
Sponsor
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
7 named
Buy side
  • G••• B•••••Deal partnerconfirmed
    “The team at D••••••• has been a joy to work with.” said G••• B•••••, Managing Director at DWHP.
  • Toronto, ON (March 15, 2024) – D• H••••••••• P••••••• (“DWHP”) a healthcare-focused private equity firm, announced today the sale of D••••••• H••••• I• I••• (“D•••••••”) to F••••••••• S•••••• G••• (“F•••••••••”), a portfolio company of E•• P•••••••.
  • Toronto, ON (March 15, 2024) – D• H••••••••• P••••••• (“DWHP”) a healthcare-focused private equity firm, announced today the sale of D••••••• H••••• I• I••• (“D•••••••”) to F••••••••• S•••••• G••• (“F•••••••••”), a portfolio company of E•• P•••••••.
Sell side
Side not stated
  • J••• B••••••, President of D•••••••, said, “D••••••• and F••••••••• are two complementary businesses that together create a strong global player in skin imaging and dermoscopy.
  • “We would like to thank the team at DWHP for their support over the last three years.” said T••••••• T•••••••••, Chief Product Officer at D•••••••.
  • D• H••••••••• P••••••• Announces Sale of D••••••• to F•••••••••
Evidence
D• H••••••••• P••••••• Announces Sale of D••••••• to F•••••••••